I went through the quarterly today and despite the hopeless management and communication my investment thesis for these assets remains unchanged. They have some cracker tenements with massive potential and are well funded to make a discovery. I topped up again, hopefully the excuses from management about lab delays don’t run into another quarter.
Ann: March 2022 Quarterly Activities Report and Appendix 5B, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
-0.002(5.88%) |
Mkt cap ! $12.52M | |||
| Open | High | Low | Value | Volume |
| 3.2¢ | 3.3¢ | 3.2¢ | $23.09K | 703.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 116138 | 3.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.3¢ | 359618 | 1 |
View Market Depth
| Last trade - 15.31pm 23/06/2025 (20 minute delay) ? |
| FG1 (ASX) Chart |